Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers

Dr. Mohammad H. Fekrazad, MD

(Dr. Mohammad Houman Fekrazad, MD)

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

615 West Avenue L
Lancaster, CA 93534

(833) KP4-CARE

Dr. Mohammad H. Fekrazad, MD is a medical oncologist in Valencia, CA specializing in medical oncology, adult oncology and adult hematology. Dr. Mohammad H. Fekrazad, MD is affiliated with Antelope Valley Medical Center.

Office Locations

28860 Plaza De Oro
Valencia, CA 91354

(708) 997-4666

open_in_new

Antelope Valley Medical Center

615 West Avenue L
Lancaster, CA 93534

(833) KP4-CARE

open_in_new

In The News

“Dr. M. Houman Fekrazad will be sharing about his personal experience with cancer and how his journey lead him to pursue clinical research on his now patented chemo patch, Eglseder said.”—"NextSCV looks to inspire with City of Hope", Santa Clarita Valley Signal, August 2018

“M. Houman Fekrazad, M.D., left, looks at a donated hat with Thomas Joseph, M.D. at City of Hope in Valencia on Wednesday, Nov. 22, 2017.”—"Organizations partner to provide donations to City of Hope patients", Santa Clarita Valley Signal, November 2017

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

Volume of procedures performed by Dr. Mohammad H. Fekrazad, MD for Medicare patients.

doctor visit	309

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Mohammad H. Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2013 were hospital care and inpatient care.

Volume of procedures performed by Dr. Mohammad H. Fekrazad, MD for Medicare patients.

doctor visit	407
hospital care	20
inpatient care	20

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Mohammad H. Fekrazad, MD.

**Gender**
Male	73
Female	72

**Ethnicity**
Non-Hispanic White	74
Black	0
Hispanic	54
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	55
From 75 to 84	0
85 and over	0
Less than 65	50

Conditions of Medicare patients treated by Dr. Mohammad H. Fekrazad, MD in 2013

Hypertension	51
High Cholesterol	32
Stroke	0
Ischemic Heart Disease	26
Depression	32
Chronic Kidney Disease	17
Asthma	0
Osteoperosis	0
Atrial Fibrilation	8
Heart Failure	18
Chronic Obstructive Pulmonary Disease	17
Diabetes	23
Dementia	10
Cancer	40

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Mohammad H. Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2014 were port flush, chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.

Volume of procedures performed by Dr. Mohammad H. Fekrazad, MD for Medicare patients.

biological response modifier (BRM) therapy	84
chemotherapy	84
doctor visit	451
minimally invasive procedures	84
port flush	94

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Mohammad H. Fekrazad, MD.

**Gender**
Male	119
Female	153

**Ethnicity**
Non-Hispanic White	174
Black	30
Hispanic	50
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	111
From 75 to 84	74
85 and over	29
Less than 65	58

Conditions of Medicare patients treated by Dr. Mohammad H. Fekrazad, MD in 2014

Hypertension	61
High Cholesterol	45
Stroke	6
Ischemic Heart Disease	40
Depression	21
Chronic Kidney Disease	28
Asthma	8
Osteoperosis	9
Atrial Fibrilation	8
Heart Failure	20
Chronic Obstructive Pulmonary Disease	20
Diabetes	32
Dementia	10
Cancer	44

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Mohammad H. Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2015 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and port flush.

Volume of procedures performed by Dr. Mohammad H. Fekrazad, MD for Medicare patients.

biological response modifier (BRM) therapy	289
chemotherapy	289
doctor visit	752
hormone therapy	35
hospital care	28
inpatient care	28
minimally invasive procedures	374
port flush	53

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Mohammad H. Fekrazad, MD.

**Gender**
Male	234
Female	250

**Ethnicity**
Non-Hispanic White	354
Black	58
Hispanic	48
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	230
From 75 to 84	132
85 and over	52
Less than 65	70

Conditions of Medicare patients treated by Dr. Mohammad H. Fekrazad, MD in 2015

Hypertension	69
High Cholesterol	45
Stroke	8
Ischemic Heart Disease	45
Depression	18
Chronic Kidney Disease	33
Asthma	19
Osteoperosis	13
Atrial Fibrilation	12
Heart Failure	21
Chronic Obstructive Pulmonary Disease	29
Diabetes	34
Dementia	12
Cancer	49

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Mohammad H. Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2016 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and port flush.

Volume of procedures performed by Dr. Mohammad H. Fekrazad, MD for Medicare patients.

biological response modifier (BRM) therapy	453
chemotherapy	453
doctor visit	1236
hormone therapy	93
hospital care	15
inpatient care	15
minimally invasive procedures	582
port flush	122

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Mohammad H. Fekrazad, MD.

**Gender**
Male	155
Female	177

**Ethnicity**
Non-Hispanic White	235
Black	33
Hispanic	42
Asian	11
Other	0
Native American	0

**Age**
From 65 to 74	165
From 75 to 84	94
85 and over	26
Less than 65	47

Conditions of Medicare patients treated by Dr. Mohammad H. Fekrazad, MD in 2016

Hypertension	70
High Cholesterol	49
Stroke	7
Ischemic Heart Disease	50
Depression	22
Chronic Kidney Disease	40
Asthma	28
Osteoperosis	12
Atrial Fibrilation	10
Heart Failure	22
Chronic Obstructive Pulmonary Disease	28
Diabetes	33
Dementia	11
Cancer	52

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Mohammad H. Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2017 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hormone therapy.

Volume of procedures performed by Dr. Mohammad H. Fekrazad, MD for Medicare patients.

biological response modifier (BRM) therapy	226
chemotherapy	226
doctor visit	1031
hormone therapy	99
hospital care	61
inpatient care	61
minimally invasive procedures	308
port flush	86

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Mohammad H. Fekrazad, MD.

**Gender**
Male	193
Female	187

**Ethnicity**
Non-Hispanic White	256
Black	41
Hispanic	51
Asian	17
Other	0
Native American	0

**Age**
From 65 to 74	169
From 75 to 84	116
85 and over	42
Less than 65	53

Conditions of Medicare patients treated by Dr. Mohammad H. Fekrazad, MD in 2017

Hypertension	73
High Cholesterol	47
Stroke	4
Ischemic Heart Disease	46
Depression	23
Chronic Kidney Disease	44
Asthma	8
Osteoperosis	10
Atrial Fibrilation	10
Heart Failure	23
Chronic Obstructive Pulmonary Disease	26
Diabetes	38
Dementia	11
Cancer	49

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Mohammad H. Fekrazad, MD treated as a medical oncologist in Valencia, CA during 2018 were hospital care, inpatient care, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mohammad H. Fekrazad, MD for Medicare patients.

biological response modifier (BRM) therapy	232
chemotherapy	232
doctor visit	975
hormone therapy	76
hospital care	313
inpatient care	313
minimally invasive procedures	254
port flush	39
urologic procedures	26

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Mohammad H. Fekrazad, MD.

**Gender**
Male	206
Female	262

**Ethnicity**
Non-Hispanic White	312
Black	46
Hispanic	67
Asian	31
Other	0
Native American	0

**Age**
From 65 to 74	201
From 75 to 84	137
85 and over	54
Less than 65	76

Conditions of Medicare patients treated by Dr. Mohammad H. Fekrazad, MD in 2018

Hypertension	75
High Cholesterol	54
Stroke	7
Ischemic Heart Disease	49
Depression	27
Chronic Kidney Disease	48
Asthma	11
Osteoperosis	12
Atrial Fibrilation	12
Heart Failure	34
Chronic Obstructive Pulmonary Disease	30
Diabetes	41
Dementia	18
Cancer	45

Medicare Procedure and Patient Information

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Mohammad H. Fekrazad, MD.

**Gender**
Male	12
Female	12

**Ethnicity**
Non-Hispanic White	0
Black	13
Hispanic	0
Asian	0
Other	0
Native American	0

Conditions of Medicare patients treated by Dr. Mohammad H. Fekrazad, MD in 2023

Hypertension	50
High Cholesterol	0
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2023

Volume of procedures performed by Dr. Mohammad H. Fekrazad, MD for Medicare patients.

The highest averages for the top procedures that Dr. Mohammad H. Fekrazad, MD treated as a medical oncologist in Valencia, CA were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

biological response modifier (BRM) therapy	256
chemotherapy	256
doctor visit	737
hormone therapy	75
hospital care	87
inpatient care	87
minimally invasive procedures	320
urologic procedures	26

Average Medicare Patient Data From 2012 - 2023

Information about Medicare patients treated by Dr. Mohammad H. Fekrazad, MD.

**Gender**
Male	124
Female	139

**Ethnicity**
Black / African American	27
Asian / Pacific Islander	7
Non-Hispanic White	175
Hispanic	39
Native American / Alaskan Native	0
Other	0

**Age**
75 to 84	69
85 and over	25
Less than 65	44
65 to 74	116

Average of Total of Conditions of Medicare patients treated by Dr. Mohammad H. Fekrazad, MD From 2012 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Mohammad H. Fekrazad, MD treated were hypertension, cancer, high cholesterol and ischemic heart disease.

Hypertension	56
High Cholesterol	34
Stroke	4
Ischemic Heart Disease	32
Depression	17
Chronic Kidney Disease	26
Asthma	9
Osteoporosis	7
Heart Failure	17
Chronic Obstructive Pulmonary Disease	18
Diabetes	25
Atrial Fibrillation	7
Cancer	34
Dementia	9

Education & Training

He is certified by the Board Certification: Hematology and has a state license in New Mexico.

Board Certification: Board Certification: Hematology

Licensed In: New Mexico

Affiliations & Hospitals

Dr. Mohammad H. Fekrazad, MD is associated with these hospitals and organizations:

Antelope Valley Medical Center

Ratings & Reviews

Dr. Mohammad H. Fekrazad, MD does not have any reviews yet, be the first to leave a review of Dr. Mohammad H. Fekrazad, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Mohammad H. Fekrazad, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Genentech USA, Inc.	$54,894 Avastin $37,055	TARCEVA $15,648	TECENTRIQ $2,174	Alecensa $17
Amgen Inc.	$48,056 Kyprolis $44,980	Vectibix $51	XGEVA $25	$3,000
Novartis Pharmaceuticals Corporation	$253 SANDOSTATIN LAR $154	TAFINLAR $24	VOTRIENT $24	PROMACTA $23	TASIGNA $17	Other $11
E.R. Squibb & Sons, L.L.C.	$251 OPDIVO $134	ERBITUX $87	ELIQUIS $12	$18
Merck Sharp & Dohme Corporation	$90 KEYTRUDA $58	$33
Other	$453 NINLARO $101	Lenvima $78	XTANDI $50	Gilotrif $41	LYNPARZA $36	Other $146

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$93,815
Travel and Lodging	$6,230
Food and Beverage	$3,937
Education	$15

Research Payments

Dr. Mohammad H. Fekrazad, MD has received 5 research payments totaling $12,556.

Biography

Dr. Mohammad Fekrazad specializes in adult hematology, adult oncology, and medical oncology. He is affiliated with Antelope Valley Medical Center and Southern California Permanente Medical Group (SCPMG).